Literature DB >> 9773792

Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease.

C Sharp1, A Johnson, P Gabow.   

Abstract

Adults with autosomal dominant polycystic kidney disease (ADPKD) who have overt proteinuria (>300 mg/d) have higher mean arterial pressures, lower creatinine clearances, larger renal volumes, and a more aggressive course of renal disease than ADPKD patients without proteinuria. This study examines the relationship between proteinuria and microalbuminuria and similar factors in ADPKD children. A total of 189 children from 81 ADPKD families was included in the analysis. The ADPKD children (n = 103) had significantly greater urine protein excretion rates than the non-ADPKD children (n = 86) (3.9+/-0.3 versus 2.8+/-0.2 mg/m2 per h, P < 0.001). Children with severe renal cystic disease (> 10 cysts; n = 54) had greater protein excretion than those with moderate disease (< or = 10 cysts; n = 49) (4.4+/-0.5 versus 3.3+/-0.2 mg/m2 per h, P < 0.05). The ADPKD children had significantly greater albumin excretion rates than the non-ADPKD children (32+/-6 versus 10+/-2 mg/m2 per 24 h, P < 0.001), and a higher percentage of ADPKD children had significant microalbuminuria (>15 mg/m2 per 24 h in boys and >23 mg/m2 per 24 h in girls) than their unaffected siblings (30% versus 10%, P < 0.05). Thirty percent of ADPKD children had albuminuria and 23% had overt proteinuria. For all ADPKD children, there was no correlation between proteinuria and hypertension. However, there was a significant correlation between urinary protein excretion and diastolic BP among children diagnosed after the first year of life (r = 0.23, P < 0.05). Therefore, proteinuria and albuminuria occur early in the course of ADPKD and may be markers of more severe renal disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773792     DOI: 10.1681/ASN.V9101908

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  17 in total

1.  Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Amirali Masoumi; Kim McFann; John D Strain; Robert W Schrier
Journal:  Contemp Clin Trials       Date:  2011-01-23       Impact factor: 2.226

2.  Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease.

Authors:  Luciano Selistre; Vandréa de Souza; Bruno Ranchin; Aoumeur Hadj-Aissa; Pierre Cochat; Laurence Dubourg
Journal:  Pediatr Nephrol       Date:  2012-06-12       Impact factor: 3.714

Review 3.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

Review 4.  From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.

Authors:  Djalila Mekahli; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2013-01-24       Impact factor: 3.714

Review 5.  The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.

Authors:  Bharathi V Reddy; Arlene B Chapman
Journal:  Pediatr Nephrol       Date:  2016-03-31       Impact factor: 3.714

Review 6.  Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.

Authors:  Dana Rizk; Arlene Chapman
Journal:  Pediatr Nephrol       Date:  2008-02-08       Impact factor: 3.714

Review 7.  Nephrotic syndrome and autosomal dominant polycystic kidney disease.

Authors:  Bianca Visciano; Renata A Di Pietro; Roberta Rossano; Antonio Mancini; Pasquale Zamboli; Bruno Cianciaruso; Antonio Pisani
Journal:  Clin Kidney J       Date:  2012-11-11

8.  A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.

Authors:  Harpreet Bhutani; Vikram Smith; Frederic Rahbari-Oskoui; Ankush Mittal; Jared J Grantham; Vicente E Torres; Michal Mrug; Kyongtae T Bae; Zhiyuan Wu; Yinghui Ge; Doug Landslittel; Patrice Gibbs; W Charles O'Neill; Arlene B Chapman
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

Review 9.  Autosomal dominant polycystic kidney disease: recent advances in clinical management.

Authors:  Zhiguo Mao; Jiehan Chong; Albert C M Ong
Journal:  F1000Res       Date:  2016-08-18

Review 10.  Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease.

Authors:  Eric G Benz; Erum A Hartung
Journal:  Pediatr Nephrol       Date:  2021-01-21       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.